Lipoprotein(a) [Lp(a)]
The inherited cardiovascular risk factor most panels skip
Plain English
Lipoprotein(a), written as Lp(a), is a type of LDL-like particle with an extra protein attached that makes it more atherogenic than standard LDL. It is primarily determined by genetics, meaning lifestyle changes have minimal impact on it. Roughly 20% of people carry levels high enough to meaningfully raise cardiovascular risk, and most have never been tested.
The Mechanism
Lp(a) is structurally similar to LDL but has an additional protein called apolipoprotein(a) attached via a disulfide bond. This extra protein makes Lp(a) stickier: it is more prone to depositing in arterial walls and more resistant to clearance than standard LDL particles. It also interferes with the body's ability to dissolve blood clots, adding a thrombotic risk layer on top of the atherogenic one.
Lp(a) levels are roughly 90% genetically determined. Unlike LDL-C, which responds substantially to diet and exercise, Lp(a) is nearly immune to lifestyle intervention. It is set primarily at birth by the LPA gene, varies by a factor of 1,000 across individuals, and changes less than 10-15% in response to any non-pharmacological intervention studied to date.
Because standard lipid panels do not include Lp(a), most people with elevated levels have no idea they carry the risk. European cardiovascular guidelines recommend testing Lp(a) at least once in every adult's lifetime. The American Heart Association now considers elevated Lp(a) above 125 nmol/L (roughly 50 mg/dL) a major independent cardiovascular risk factor.
Why It Matters
Test it once. It changes how you interpret everything else.
If you have elevated Lp(a), your cardiovascular risk is meaningfully higher than your LDL-C, ApoB, or triglyceride numbers alone would suggest. Knowing your Lp(a) changes the risk calculus: it is a strong argument for more aggressive LDL-C targets, earlier statin consideration, and closer monitoring. It also means that if heart disease runs in your family despite clean-looking standard lipid panels, Lp(a) may be the hidden driver.
Common Misconception
Most people assume that if their LDL-C is good and they eat well, their cardiovascular risk is under control. Elevated Lp(a) operates independently of diet and exercise: you can have an LDL-C of 80 mg/dL, no metabolic dysfunction, and still carry substantially elevated cardiovascular risk if Lp(a) is above 125 nmol/L. It is not a failure of lifestyle. It is genetics, and it needs to be known.
What a Healthy Range Looks Like
Normal
<75 nmol/L
No additional Lp(a)-related cardiovascular risk beyond standard LDL and metabolic factors
Borderline
75–125 nmol/L
Modest Lp(a) contribution to risk; warrants closer monitoring of other cardiovascular markers
Elevated
125–200 nmol/L
Independent major cardiovascular risk factor; impacts LDL-C targets and intervention thresholds
High Risk
>200 nmol/L
Substantially elevated risk; equivalent to familial hypercholesterolemia in cardiovascular impact
Lp(a) is sometimes reported in mg/dL and sometimes in nmol/L, and the conversion is not 1:1; 50 mg/dL is approximately 125 nmol/L but varies by assay. Confirm which unit your lab uses. Unlike most biomarkers, trending over time is less meaningful here because Lp(a) changes minimally with intervention.
Signs It Is Disrupted
- Family history of early cardiovascular disease (heart attack or stroke before age 55 in men, 65 in women) with otherwise clean-looking standard lipid panels
- Personal history of premature cardiovascular events despite normal LDL-C and metabolic markers
- Diagnosed familial hypercholesterolemia, which has a high prevalence of concurrent elevated Lp(a)
- Standard lipid panels look acceptable but ApoB is disproportionately elevated relative to LDL-C
How to Improve It
3 Things to Remember
Lp(a) is roughly 90% genetically determined and does not meaningfully respond to diet, exercise, or standard lipid-lowering lifestyle changes.
Elevated Lp(a) above 125 nmol/L is an independent major cardiovascular risk factor that standard lipid panels miss entirely; it should be tested at least once in every adult.
If Lp(a) is elevated, the primary management strategy is aggressive LDL-C reduction to lower total atherogenic burden while awaiting specific Lp(a)-targeting therapies.
Appears In
Related Terms
Protocol
Turn what you've learned into daily practice
Protocol pulls your wearable and nutrition data together into a daily health score, morning brief, and AI coaching. All in one place.
Get started free